Speaker(s): 

M. Amer Swid, MD, Resident Physician, Geisinger - has nothing to disclose.

Haluk Kavus, MD, Resident Physician, Geisinger - has nothing to disclose.

Moderator(s): 

Zachary Hoffer, MD, Pathology Residency Program Director, Geisinger - has nothing to disclose. 

Learning Objectives: 

At the conclusion of this session, the participant should be able to: 

• Explain evidence-based strategies for managing blood component shortages, emphasizing adherence to guidelines during mild shortages and resourcefulness during severe shortages.
• Describe the importance of balancing safety considerations with the need to extend the blood supply during critical shortages, emphasizing the role of sound medical judgment and practical approaches.
• Discuss the limitations of liquid biopsy testing
• Evaluate the possible future use of liquid biopsy testing in Hematolymphoid neoplasms

Disclosure of Relevant Financial Relationships with/without Commercial Interests:

The Planning Committee consisting of Zachary S. Hoffer, MD have no identified disclosures. 

CE Committee Member/Content Reviewers have nothing to disclose. 

Any/All relevant financial relationships have been mitigated. 

Content Disclosure: 

This presentation/content is HIPPA compliant. 

Commerical Support for this Session: 

None.